Synergy china registry.It was reported that coronary atherosclerotic heart disease occurred.In (b)(6) 2019, the subject presented with myocardial infarction and was referred for cardiac catheterization.Index procedure was performed.The target lesion was located in the mid left anterior descending (lad) with 100 % stenosis and was 16 mm long, with a reference vessel diameter of 2.5 mm.The target lesion was treated with pre-dilatation and placement of 2.50 mm x 16 mm synergy stent system.Following post dilatation, residual stenosis was 0%.Seven days later, in (b)(6) 2020, the subject was discharged on aspirin and ticagrelor.In (b)(6) 2022, the subject was diagnosed with coronary atherosclerotic heart disease and was hospitalized on the same day for further evaluation and treatment.Medication was given to treat the event.Five days later, the event was considered to be recovered and resolved.The subject was discharged on the same day on aspirin and ticagrelor.
|